Compare ACIU & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACIU | NATR |
|---|---|---|
| Founded | 2003 | 1972 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.7M | 188.4M |
| IPO Year | 2015 | 1995 |
| Metric | ACIU | NATR |
|---|---|---|
| Price | $1.98 | $10.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $8.36 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 216.7K | 198.9K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.00 |
| EPS | N/A | ★ 0.59 |
| Revenue | N/A | ★ $480,144,000.00 |
| Revenue This Year | $422.39 | N/A |
| Revenue Next Year | $377.85 | $2.59 |
| P/E Ratio | ★ N/A | $17.25 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $2.00 | $9.38 |
| 52 Week High | $3.90 | $28.14 |
| Indicator | ACIU | NATR |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 33.84 |
| Support Level | N/A | $9.38 |
| Resistance Level | $2.49 | $12.99 |
| Average True Range (ATR) | 0.15 | 0.54 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 0.00 | 24.39 |
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.